Allen Adolphe, MD
Internal Medicine · Albuquerque, NMNPI 1275556508
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (58.9%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Lilly USA, LLC accounts for 99.4% of it on its own, with 1 other manufacturer making up the rest. Among internal medicine clinicians in NM with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 38 payments — averaging $111.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$4K
- The Binding Site Inc.$25
Across 87 payments — averaging $1148.81 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novo Nordisk AS$64K
- Gilead$16K
- AbbVie$14K
- Sanofi US Services Inc.$5K
- Novo Nordisk$2K
What the payments were for
- Consulting fees$2,50059%
- Travel & lodging$1,27730%
- Food & beverage$43910%
- Gifts$251%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 37 | $4,216 |
| The Binding Site Inc. | 1 | $25 |
How this compares
$4,241 in reported general payments places this provider in the 95th percentile of 578 internal medicine providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 29 | $37,659 |
| XareltoRivaroxaban | 13 | $20,548 |
| Testosterone | 13 | $4,751 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 15 | $4,459 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 41 | $1,219 |
| Memantine Hcl ErMemantine Hcl | 18 | $890 |
| Oxycodone Hcl | 18 | $691 |
| Levothyroxine Sodium | 45 | $673 |
| Baclofen | 30 | $591 |
| Rosuvastatin Calcium | 51 | $561 |
| Gabapentin | 29 | $497 |
| Metoprolol Succinate | 23 | $410 |
| Lisinopril | 29 | $381 |
| Finasteride | 16 | $381 |
| Irbesartan | 18 | $369 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Albuquerque
- Edward LewieckiAlbuquerque$491K
- James AdairAlbuquerque$108K
- Gulshan ParasherAlbuquerque$66K
- Mark WalkerAlbuquerque$24K
- Joao TeixeiraAlbuquerque$18K
- Karla AlmarazAlbuquerque$18K
- David SosaAlbuquerque$11K
- Revati ReddyAlbuquerque$7K
- Ross DavidsonAlbuquerque$7K
- Edmee RodriguezAlbuquerque$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.